Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

Delayed Quote. Delayed Nasdaq - 03/04 04:14:59 pm
120.05 USD   -2.81%
02/11 VERTEX PHARMACE : to Present at Upcoming Investor Conferences
02/08DJDrug Making Breaks Away From Its Old Ways
01/28 VERTEX PHARMACE : 4Q loss is deeper than expected
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on VERTEX PHARMACEUTICALS INC
03/04 VERTEX PHARMACEUTICALS : Findings on Photochemistry Detailed by Investigators at..
02/26 VERTEX PHARMACEUTICALS : Researchers at Vertex Pharmaceuticals Release New Data ..
02/20 VERTEX PHARMACEUTICALS : to Present at Upcoming Investor Conferences
02/12 VERTEX PHARMACEUTICALS : New Findings on Medicinal Chemistry from Vertex Pharmac..
02/11 VERTEX PHARMACEUTICALS : to Present at Upcoming Investor Conferences
02/08DJDrug Making Breaks Away From Its Old Ways
02/01 DEUTSCHE BANK : Vertex Pharmaceuticals PT Raised to $155.00 at Deutsche Bank (VR..
01/28 VERTEX PHARMACEUTICALS : 4Q loss is deeper than expected
01/28 VERTEX PHARMACEUTICALS : Reports Full-Year and Fourth Quarter 2014 Financial Res..
01/14 VERTEX PHARMACEUTICALS : Announces Upcoming Presentation at the J.P. Morgan Heal..
01/11 VERTEX PHARMACEUTICALS : Pharma Expects 2015 Kalydeco Revenues Of $560 Mln To $5..
01/11 VERTEX PHARMACEUTICALS : Outlines 2015 Business Priorities
01/11 VERTEX PHARMACEUTICALS : Outlines 2015 Business Priorities to Support the Develo..
01/08 VERTEX PHARMACEUTICALS : Reports Summarize Magnetic Resonance Research Findings ..
01/08 VERTEX PHARMACEUTICALS : U.S. Food and Drug Administration Approves KALYDECO® iv..
01/08 VERTEX PHARMACEUTICALS : New Findings from Vertex Pharmaceuticals Inc. in the Ar..
01/08 VERTEX PHARMACEUTICALS : Investigators at Vertex Pharmaceuticals Inc. Discuss Fi..
01/07 VERTEX PHARMACEUTICALS : Recent Research from Vertex Pharmaceuticals Inc. Highli..
01/06 VERTEX PHARMACEUTICALS : Announces Upcoming Presentation at the J.P. Morgan Heal..
01/05 VERTEX PHARMACEUTICALS : FDA OKs Kalydeco for Use in People with Cystic Fibrosis..
01/02 S&P 500 MOVERS : Dnr, vrtx
01/01 VERTEX PHARMACEUTICALS : Investigators from Vertex Pharmaceuticals Have Reported..
2014 VERTEX PHARMACEUTICALS : Appoints David Altshuler, M.D., Ph.D. as EVP of Global ..
2014 VERTEX PHARMACEUTICALS : U.S. Food and Drug Administration Approves KALYDECO® (i..
2014 VERTEX PHARMACEUTICALS : Investigators from Vertex Pharmaceuticals Have Reported..
2014 VERTEX PHARMACEUTICALS : Appoints David Altshuler, M.D., Ph.D. as EVP of Global ..
2014 VERTEX PHARMACEUTICALS : Findings on Medicinal Chemistry Reported by Investigato..
2014 VERTEX PHARMACEUTICALS : MA : Change in Directors or Principal Officers (form 8-..
2014 VERTEX PHARMACEUTICALS : David Altshuler, M.D., Ph.D., Joins Vertex as Executive..
2014 S&P 500 MOVERS : Nbr, celg
2014 NASDAQ 100 MOVERS : Vip, celg
2014 VERTEX PHARMACEUTICALS : Patent Issued for Pyrazolopyrazine Kinase Inhibitors
2014 U.S. Patents Awarded to Inventors in Pennsylvania (Dec. 2)
2014 VERTEX PHARMACEUTICALS : Assigned Patent
2014 VERTEX PHARMACEUTICALS : Alios BioPharma, Vertex Pharmaceuticals Assigned Patent
2014 VERTEX PHARMACEUTICALS : to Present at Deutsche Bank BioFEST on December 2
2014 VERTEX PHARMACEUTICALS : Assigned Patent
2014 VERTEX PHARMACEUTICALS : Foundation sells $3.3B in Vertex drug royalties
2014 NASDAQ 100 MOVERS : Vrtx, adsk
2014 VERTEX PHARMACEUTICALS : Royalty Pharma pays $3.3 billion for CFF royalty rights..
2014 VERTEX PHARMACEUTICALS : to Present at Deutsche Bank BioFEST on December 2
2014 NASDAQ 100 MOVERS : Gmcr, dltr
2014 VERTEX PHARMACEUTICALS : Studies Conducted at Vertex Pharmaceuticals Inc. on Org..
2014 VERTEX PHARMACEUTICALS : Foundation sells $3.3B in Vertex drug royalties
2014 VERTEX PHARMACEUTICALS : U.S. Patents Awarded to Inventors in West Virginia (Nov..
2014 VERTEX PHARMACEUTICALS : Assigned Patent
2014 VERTEX PHARMACEUTICALS : Submits Applications in the U.S. and Europe for Approva..
2014 VERTEX PHARMACEUTICALS : MA Management's Discussion and Analysis of Financial Co..
2014 VERTEX PHARMACEUTICALS : to Present at the Credit Suisse Healthcare Conference o..
2014 VERTEX PHARMACEUTICALS : S&P 500 Analyst Moves: VRTX
2014 VERTEX PHARMACEUTICALS : Submits Applications in the U.S. and Europe for Approva..
2014 VERTEX PHARMACEUTICALS : Assigned Patent
2014 VERTEX PHARMACEUTICALS : to Present at the Credit Suisse Healthcare Conference o..
2014 VERTEX PHARMACEUTICALS : Aileron Therapeutics Expands Senior Management Team
2014 VERTEX PHARMACEUTICALS : FDA Advisory Committee Recommends Approval of KALYDECO®..
2014 VERTEX PHARMACEUTICALS : Patent Issued for Thiazoles, Imidazoles, and Pyrazoles ..
2014 NASDAQ 100 MOVERS : Fb, wdc
2014 VERTEX PHARMACEUTICALS : tops Street 3Q forecasts
2014 VERTEX PHARMACEUTICALS : Reports Third Quarter 2014 Financial Results
2014 VERTEX PHARMACEUTICALS : Assigned Patent
2014 VERTEX PHARMACEUTICALS : to Announce Third Quarter 2014 Financial Results on Oct..
2014DJU.S. HOT STOCKS : Hot Stocks to Watch
2014 VERTEX PHARMACEUTICALS : FDA Advisory Committee Recommends Approval of KALYDECO®..
2014 VERTEX PHARMACEUTICALS : Health and Human Services Department (HHS); Food and Dr..
2014 AbbVie board ditches planned $55 billion Shire acquisition
2014 VERTEX PHARMACEUTICALS : Patent Issued for Modulators of ATP-Binding Cassette Tr..
2014 VERTEX PHARMACEUTICALS : Patent Issued for Multiwell Assay Apparatus and Method ..
2014 VERTEX PHARMACEUTICALS : Patent Issued for Thiophene-Carboxamides Useful as Inhi..
2014 VERTEX PHARMACEUTICALS : to Announce Third Quarter 2014 Financial Results on Oct..
2014 Wall St. drops in late selloff; worst three days for S&P 500 since 2011
2014 NASDAQ 100 MOVERS : Tsla, vrtx
2014 VERTEX PHARMACEUTICALS : Health and Human Services Department (HHS); Food and Dr..
2014 SENIOR HOUSING PROPERTIES : Vertex Pharmaceuticals Biotech Buildings Gets LEED G..
2014 VERTEX PHARMACEUTICALS : Reviews Recent Progress and Announces Upcoming Mileston..
2014 VERTEX PHARMACEUTICALS : Patent Issued for Solid Forms of 3-(6-(1-(2,2-Difluorob..
1  2  3  4  5  6  7  8Next
Advertisement
Chart
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF